Chapter 2 From Microbial Products to Novel Drugs that Target a Multitude of Disease Indications

Methods in Enzymology

Volumn 458, Issue A, 2009, Pages 29-58

  Marinelli, Flavia ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CALICHEAMICIN; COMPACTIN; CYCLOSPORIN A; DACTINOMYCIN; DEFEROXAMINE MESYLATE; ENEDIYNE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; MEVINOLIN; MITOMYCIN C; MYCOPHENOLIC ACID; PACLITAXEL; PENTOSTATIN; RAPAMYCIN; REBECCAMYCIN; TACROLIMUS; TAXANE DERIVATIVE; TERPENE DERIVATIVE;

ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; BIOTECHNOLOGY; CARDIOVASCULAR DISEASE; CHOLESTEROL SYNTHESIS; CLINICAL PRACTICE; CYANOBACTERIUM; DNA DAMAGE; DRUG ACTIVITY; DRUG DETERMINATION; DRUG TARGETING; FUNGUS; LIVER; METABOLIC DISORDER; METABOLITE; MICROBIAL DIVERSITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; STREPTOMYCES; TREATMENT INDICATION;

ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIFUNGAL AGENTS; IMMUNOSUPPRESSIVE AGENTS; MOLECULAR STRUCTURE;

ACTINOBACTERIA (CLASS); CYANOBACTERIA; FUNGI; MYXOCOCCALES; PSEUDOMONAS; STREPTOMYCES;

EID: 64249124472     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(09)04802-2     Document Type: Review

References (66)

1. Alberts A.W., Chen J., Kuron G., Hunt V., Huff J., Hoffman C., Rothrock J., Lopez M., Joshua H., Harris E., Patchett A., Monaghan R., et al. Mevinolin: A highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc. Natl. Acad. Sci. USA 77 (1980) 3957-3961
2. Belcourt M.F., Penketh P.G., Hodnick W.F., Johnson D.A., Sherman D.H., Rockwell S., and Sartorelli A.C. Mitomycin resistance in mammalian cells expressing the bacterial mitomycin C resistance protein MCRA. Proc. Natl. Acad. Sci. USA 96 (1999) 10489-10494
3. Beltrametti F., Rossi R., Selva E., and Marinelli F. Antibiotic production improvement in the rare actinomycete Planobsipora rosea by selection of resistance mutations to the aminoglycosides streptomycin and gentamycin and to rifamycin. J. Ind. Microbiol. Biotechnol. 34 (2006) 283-288
4. Berdy J. Bioactive microbial metabolites. J. Antibiot. (Tokyo) 58 (2005) 1-26
5. Biondi N., Tredici M.R., Taton A., Wilmotte A., Hodgson D.A., Losi D., and Marinelli F. Cyanobacteria from benthic mats of Antarctic lakes as a source of new bioactivities. J. Appl. Microbiol. 105 (2008) 105-115
6. Borel J.F., Feurer C., Gubler H.U., and Stahelin H. Biological effects of cyclosporin A: A new antilymphocytic agent. Agents Actions 6 (1976) 468-475
7. Brandi L., Lazzarini A., Cavaletti L., Abbondi M., Corti E., Ciciliato I., Gastaldo L., Marazzi A., Feroggio M., Fabbretti A., Maio A., Colombo L., et al. Novel tetrapeptide inhibitors of bacterial protein synthesis produced by a Streptomyces sp. Biochemistry 45 (2006) 3692-3702
8. Brown A.G., Smale T.C., King T.J., Hasenkamp R., and Thompson R.H. Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum. J. Chem. Soc. [Perkin 1] (1976) 1165-1170
9. Bu'Lock J.D. Intermediary metabolism and antibiotic synthesis. Adv. Appl. Microbiol. 3 (1961) 293-342
10. Castiglione F., Cavaletti L., Losi D., Lazzarini A., Carrano L., Feroggio M., Ciciliato I., Corti E., Candiani G., Marinelli F., and Selva E. A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp. Biochemistry 46 (2007) 5884-5895
11. Castiglione F., Lazzarini A., Carrano L., Corti E., Ciciliato I., Gastaldo L., Candiani P., Losi D., Marinelli F., Selva E., and Parenti F. Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens. Chem. Biol. 15 (2008) 22-31
12. Challis G.L., and Hopwood D.A. Synergy and contingency as driving forces for the evolution of multiple secondary metabolite production by Streptomyces species. Proc. Natl. Acad. Sci. USA 100 (2003) 14555-14561
13. Cragg G.M. Paclitaxel (Taxol): A success story with valuable lessons for natural product drug discovery and development. Med. Res. Rev. 18 (1998) 315-331
14. Davies J., Spiegelman G.B., and Yim G. The world of subinhibitory antibiotic concentrations. Curr. Opin. Microbiol. 9 (2006) 445-453
15. Demain A.L., and Adrio J.L. Contributions of microorganisms to industrial biology. Mol. Biotechnol. 38 (2008) 41-55
16. Ding Y., Seufert W.H., Beck Z.Q., and Sherman D.H. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity. J. Am. Chem. Soc. 130 (2008) 5492-5498
17. Du L., Sanchez C., Chen M., Edwards D.J., and Shen B. The biosynthetic gene cluster for the antitumor drug bleomycin from Streptomyces verticillus ATCC15003 supporting functional interactions between nonribosomal peptide synthetases and a polyketide synthase. Chem. Biol. 7 (2000) 623-642
18. Endo A. Monacolin K, a new hypocholesterolemic agent that specifically inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Antibiot. (Tokyo) 33 (1980) 334-336
19. Endo A., Kuroda M., and Tanzawa K. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett. 72 (1976) 323-326
20. Fabre B., Armau E., Etienne G., Legendre F., and Tiraby G. A simple screening method for insecticidal substances from actinomycetes. J. Antibiot. (Tokyo) 41 (1988) 212-219
21. Fajardo A., and Martinez J.L. Antibiotics as signals that trigger specific bacterial responses. Curr. Opin. Microbiol. 11 (2008) 161-167
22. Galm U., Hager M.H., Van Lanen S.G., Ju J., Thorson J.S., and Shen B. Antitumor antibiotics: Bleomycin, enediynes, and mitomycin. Chem. Rev. 105 (2005) 739-758
23. Galm U., Wang L., Wendt-Pienkowski E., Yang R., Liu W., Tao M., Coughlin J.M., and Shen B. In vivo manipulation of the bleomycin biosynthetic gene cluster in Streptomyces verticillus ATCC15003 revealing new insights into its biosynthetic pathway. J. Biol. Chem. 283 (2008) 28236-28245
24. Gaspari F., Paitan Y., Mainini M., Losi D., Ron E.Z., and Marinelli F. Myxobacteria isolated in Israel as potential source of new anti-infectives. J. Appl. Microbiol. 98 (2005) 429-439
25. Gerth K., Bedorf N., Hofle G., Irschik H., and Reichenbach H. Epothilons A and B: Antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties. J. Antibiot. (Tokyo) 49 (1996) 560-563
26. Gong G.L., Sun X., Liu X.L., Hu W., Cao W.R., Liu H., Liu W.F., and Li Y.Z. Mutation and a high-throughput screening method for improving the production of epothilones of Sorangium. J. Ind. Microbiol. Biotechnol. 34 (2007) 615-623
27. Gust B., Chandra G., Jakimowicz D., Yuqing T., Bruton C.J., and Chater K.F. Lambda red-mediated genetic manipulation of antibiotic-producing Streptomyces. Adv. Appl. Microbiol. 54 (2004) 107-128
28. Hyun C.G., Kim S.Y., Hur J.H., Seo M.J., Suh J.W., and Kim S.O. Molecular detection of alpha-glucosidase inhibitor-producing actinomycetes. J. Microbiol. 43 (2005) 313-318
29. Istvan E.S., and Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292 (2001) 1160-1164
30. Julien B., and Shah S. Heterologous expression of epothilone biosynthetic genes in Myxococcus xanthus. Antimicrob. Agents Chemother. 46 (2002) 2772-2778
31. Kennedy J., Auclair K., Kendrew S.G., Park C., Vederas J.C., and Hutchinson C.R. Modulation of polyketide synthase activity by accessory proteins during lovastatin biosynthesis. Science 284 (1999) 1368-1372
32. Kino T., Hatanaka H., Hashimoto M., Nishiyama M., Goto T., Okuhara M., Kohsaka M., Aoki H., and Imanaka H. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J. Antibiot. (Tokyo) 40 (1987) 1249-1255
33. Lam K.S. New aspects of natural products in drug discovery. Trends Microbiol. 15 (2007) 279-289
34. Lawen A., and Zocher R. Cyclosporin synthetase. The most complex peptide synthesizing multienzyme polypeptide so far described. J. Biol. Chem. 265 (1990) 11355-11360
35. Lazzarini A., Cavaletti L., Toppo G., and Marinelli F. Rare genera of actinomycetes as potential producers of new antibiotics. Antonie Van Leeuwenhoek 79 (2001) 399-405
36. Lomovskaya N., Otten S.L., Doi-Katayama Y., Fonstein L., Liu X.C., Takatsu T., Inventi-Solari A., Filippini S., Torti F., Colombo A.L., et al. Doxorubicin overproduction in Streptomyces peucetius: Cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene. J. Bacteriol. 181 (1999) 305-318
37. Madduri K., Kennedy J., Rivola G., Inventi-Solari A., Filippini S., Zanuso G., Colombo A.L., Gewain K.M., Occi J.L., MacNeil D.J., et al. Production of the antitumor drug epirubicin (4′-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius. Nat. Biotechnol. 16 (1998) 69-74
38. Magarvey N.A., Beck Z.Q., Golakoti T., Ding Y., Huber U., Hemscheidt T.K., Abelson D., Moore R.E., and Sherman D.H. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts. ACS Chem. Biol. 1 (2006) 766-779
39. Mann J. Natural products as immunosuppressive agents. Nat. Prod. Rep. 18 (2001) 417-430
40. Manzoni M., and Rollini M. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs. Appl. Microbiol. Biotechnol. 58 (2002) 555-564
41. Mao Y., Varoglu M., and Sherman D.H. Molecular characterization and analysis of the biosynthetic gene cluster for the antitumor antibiotic mitomycin C from Streptomyces lavendulae NRRL 2564. Chem. Biol. 6 (1999) 251-263
42. Marinelli F. Industrial relevance of microbial diversity. Abstract Book 1st FEMS Congress of European Microbiologists (2003), Ljubljana, Slovenia 8
43. Molnar I., Schupp T., Ono M., Zirkle R., Milnamow M., Nowak-Thompson B., Engel N., Toupet C., Stratmann A., Cyr D.D., Gorlach J., Mayo J.M., et al. The biosynthetic gene cluster for the microtubule-stabilizing agents epothilones A and B from Sorangium cellulosum So ce90. Chem. Biol. 7 (2000) 97-109
44. Newman D.J., and Cragg G.M. Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70 (2007) 461-477
45. Newman D.J., and Shapiro S. Microbial prescreens for anticancer activity. SIM News 58 (2008) 132-150
46. Quesniaux V.F., Schreier M.H., Wenger R.M., Hiestand P.C., Harding M.W., and Van Regenmortel M.H. Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity. Eur. J. Immunol. 17 (1987) 1359-1365
47. Reichenbach H., and Hofle G. Discovery and development of the epothilones: A novel class of antineoplastic drugs. Drugs R D 9 (2008) 1-10
48. Reynolds K.A., and Demain A.L. Rapamycin, FK506, and ascomycin-related compounds. In: R.K.A., and D.A.L. (Eds). Biotechnology of Antibiotics. 2nd ed. (1997), Marcel Dekker, New York 497-520
49. Rippka R. Isolation and purification of cyanobacteria. Methods Enzymol. 167 (1988) 3-27
50. Sanchez C., Zhu L., Brana A.F., Salas A.P., Rohr J., Mendez C., and Salas J.A. Combinatorial biosynthesis of antitumor indolocarbazole compounds. Proc. Natl. Acad. Sci. USA 102 (2005) 461-466
51. Schauwecker F., Pfennig F., Grammel N., and Keller U. Construction and in vitro analysis of a new bi-modular polypeptide synthetase for synthesis of N-methylated acyl peptides. Chem. Biol. 7 (2000) 287-297
52. Singh S.B., Jayasuriya H., Dewey R., Polishook J.D., Dombrowski A.W., Zink D.L., Guan Z., Collado J., Platas G., Pelaez F., Felock P.J., and Hazuda D.J. Isolation, structure, and HIV-1-integrase inhibitory activity of structurally diverse fungal metabolites. J. Ind. Microbiol. Biotechnol. 30 (2003) 721-731
53. Smith C.D., Zhang X., Mooberry S.L., Patterson G.M., and Moore R.E. Cryptophycin: A new antimicrotubule agent active against drug-resistant cells. Cancer Res. 54 (1994) 3779-3784
54. Sponga F., Cavaletti L., Lazzarini A., Losi D., Borghi A., Ciciliato I., and Marinelli F. Biodiversity and potential of marine-derived microrganisms. J. Biotechnol. 70 (1999) 65-69
55. Stefanelli S., Corti E., Montanini N., Denaro M., and Sarubbi E. Inhibitors of type-I interleukin-1 receptor from microbial metabolites. J. Antibiot. (Tokyo) 50 (1997) 484-489
56. Stefanelli S., Sponga F., Ferrari P., Sottani C., Corti E., Brunati C., and Islam K. Inhibitors of myo-inositol monophosphatase, ATCC 20928 factors A and C. Isolation, physico-chemical characterization and biological properties. J. Antibiot. (Tokyo) 49 (1996) 611-616
57. Stierle A., Strobel G., and Stierle D. Taxol and taxane production by Taxomyces andreanae, an endophytic fungus of Pacific yew. Science 260 (1993) 214-216
58. Strobel G. Harnessing endophytes for industrial microbiology. Curr. Opin. Microbiol. 9 (2006) 240-244
59. Sugiyama M., and Kumagai T. Molecular and structural biology of bleomycin and its resistance determinants. J. Biosci. Bioeng. 93 (2002) 105-116
60. Tang L., Chung L., Carney J.R., Starks C.M., Licari P., and Katz L. Generation of new epothilones by genetic engineering of a polyketide synthase in Myxococcus xanthus. J. Antibiot. (Tokyo) 58 (2005) 178-184
61. Tang L., Shah S., Chung L., Carney J., Katz L., Khosla C., and Julien B. Cloning and heterologous expression of the epothilone gene cluster. Science 287 (2000) 640-642
62. Vezina C., Kudelski A., and Sehgal S.N. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. (Tokyo) 28 (1975) 721-726
63. Vining L.C. Functions of secondary metabolites. Annu. Rev. Microbiol. 44 (1990) 395-427
64. Wani M.C., Taylor H.L., Wall M.E., Coggon P., and McPhail A.T. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93 (1971) 2325-2327
65. Waterbury J.B., and Stanier R.Y. Isolation and growth of cyanobacteria from marine and hypersaline environments. In: Schlegel H.G. (Ed). The Prokaryotes: A Handbook on Habitats, Isolation, and Identification of Bacteria (1981), Springer-Verlag, Berlin, Germany 221-223
66. Zazopoulos E., Huang K., Staffa A., Liu W., Bachmann B.O., Nonaka K., Ahlert J., Thorson J.S., Shen B., and Farnet C.M. A genomics-guided approach for discovering and expressing cryptic metabolic pathways. Nat. Biotechnol. 21 (2003) 187-190